Comorbidity as a Predictor of Overall Survival in Prostate Cancer Patients Treated With External Beam Radiotherapy Combined With HDR Brachytherapy Boosts

Acta Oncologica - United Kingdom
doi 10.1080/0284186x.2016.1253864
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Both Comorbidity and Worse Performance Status Are Associated With Poorer Overall Survival After External Beam Radiotherapy for Prostate Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Treatment Outcomes of External Beam Radiotherapy Combined With High-Dose-Rate Brachytherapy in Patients With Esophageal Cancer

Siberian Journal of Oncology
Cancer ResearchOncology
2017English

Combined Brachytherapy and External Beam Radiotherapy Without Adjuvant Androgen Deprivation Therapy for High-Risk Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

A Comparison of Outcomes for Patients With Intermediate and High Risk Prostate Cancer Treated With Low Dose Rate and High Dose Rate Brachytherapy in Combination With External Beam Radiotherapy

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Mortality After Prostate Cancer Treatment With Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity

European Urology
Urology
2013English

Improved Survival in Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Goserelin

New England Journal of Medicine
Medicine
1997English

Influence of Race on Outcomes of Patients With Localized Prostate Cancer Considered Intermediate or High Risk of Biochemical Failure Treated With High Dose Rate Brachytherapy and External Beam Radiotherapy

Medical & Surgical Urology
2013English

Evaluating Radiation-Induced Changes With Diffusion Weighted Imaging in Patients With Gynecologic Cancers Treated With Combined External Beam Radiation Radiotherapy and High-Dose-Rate Brachytherapy: Initial Results

Brachytherapy
Nuclear MedicineRadiologyImagingOncology
2015English

Change in PSA Velocity Is a Predictor of Overall Survival in Men With Biochemically-Recurrent Prostate Cancer Treated With Nonhormonal Agents: Combined Analysis of Four Phase-2 Trials

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy